Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.
about
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches.Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusEvolution of silver nanoparticles in the rat lung investigated by X-ray absorption spectroscopyInfluence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lungProgress of small molecular inhibitors in the development of anti-influenza virus agents.Micro CT visualization of silver nanoparticles in the middle and inner ear of rat and transportation pathway after transtympanic injectionToxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line.Potential applications and human biosafety of nanomaterials used in nanomedicineTannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infectionSilver nanoparticles: synthesis, properties, and therapeutic applications.Different cytotoxicity responses to antimicrobial nanosilver coatings when comparing extract-based and direct-contact assays.Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections.Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus.Metal-Based Nanoparticles for the Treatment of Infectious Diseases.Exposure to silver nanoparticles affects viability and function of natural killer cells, mostly via the release of ions.Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response.Responses of intestinal virome to silver nanoparticles: safety assessment by classical virology, whole-genome sequencing and bioinformatics approaches.Antiviral Activity of Tannic Acid Modified Silver Nanoparticles: Potential to Activate Immune Response in Herpes GenitalisPreparation of Silver Nanoparticles and Their Industrial and Biomedical Applications: A Comprehensive Review
P2860
Q27690727-08057419-106F-4DB2-94AC-F73563AE8BF7Q28084005-71C7F8D5-6FBA-4957-B214-2397E7499558Q28386026-51F864F9-5AD4-4570-873C-EB7A1E93CE6EQ28390486-C52F36F1-96ED-4718-B2AD-EC185B9D9FB3Q30234943-9C131A07-8788-44A9-B42A-338C83A984D7Q30419569-0D9764B3-18FE-41FC-9816-388E9A35A9E5Q30421495-0964101B-3CC3-4069-A64C-78E160ED2486Q32944368-B51AFC46-375B-4233-B04B-82EAD6FD82A8Q34035024-5F83CFE6-385F-47F0-A25B-6744D03CA76FQ38301509-3FC7467E-8F3A-4890-BD4F-A994CEE6DD72Q38913761-58323F54-C3D9-4E7A-A99F-0C74CD57060DQ38940938-D3E7C142-6604-4F69-BF1D-D54A976F93E5Q40067248-A0F3B9BC-AF19-49BC-87E1-FD8AC22448F8Q40078347-DBA27DC6-F88A-467D-A286-CB54011E63F9Q40117478-EA09BCF4-C0A1-4F96-9ACF-5641330BE22FQ40666130-8A412693-4962-4A77-97C4-61B0A4FAAC0AQ54986897-0081C0A1-DD4F-4A50-9928-036B0D2B920EQ58692099-14821FE9-2261-4D69-97F9-69DBBE7E57B3Q59102640-174BAEAE-DD6F-4B7C-AAEB-43ACDC68B0DD
P2860
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of A/Human/Hubei/3/ ...... articles in vitro and in vivo.
@en
Inhibition of A/Human/Hubei/3/2005
@nl
type
label
Inhibition of A/Human/Hubei/3/ ...... articles in vitro and in vivo.
@en
Inhibition of A/Human/Hubei/3/2005
@nl
prefLabel
Inhibition of A/Human/Hubei/3/ ...... articles in vitro and in vivo.
@en
Inhibition of A/Human/Hubei/3/2005
@nl
P2093
P2860
P356
P1476
Inhibition of A/Human/Hubei/3/ ...... articles in vitro and in vivo.
@en
P2093
Conglong Zheng
Dongxi Xiang
Jianjian Yin
Manju Marappan
Michael Liam O'Connor
Sarah Shigdar
Xiaojuan Zhao
Xiujing Li
P2860
P304
P356
10.2147/IJN.S53622
P407
P577
2013-10-30T00:00:00Z